Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis

Current Eye Research

Volumn 34, Issue 2, 2009, Pages 145-151

  Hosseini, Hamid ^a   Mehryar, Morsal ^a   Eghtedari, Masoomeh ^a   Ahmadi, Farzin ^a   Nowroozizadeh, Sarah ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Endophthalmitis; Intravitreal; Staphylococcus epidermidis; Triamcinolone

Indexed keywords

TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENDOPHTHALMITIS; EYE INJURY; HISTOPATHOLOGY; IRITIS; KERATITIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; TISSUE INJURY; VITREORETINOPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; EYE; EYE INFECTIONS, BACTERIAL; GLUCOCORTICOIDS; INJECTIONS; MALE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 60749103688     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802585938     Document Type: Article

References (31)

1. Abu el-Asrar AM, Al-Amro SA, Al-Mosallam AA, Al-Obeidan S. Post-traumatic endophthalmitis: Causative organisms and visual outcome. Eur J Ophthalmol 1999;9:21-31.
2. Ellis MF. Topical anaesthesia: A risk factor for post-cataract-extraction endophthalmitis? Clin Experiment Ophthalmol 2003;31:125-128.
3. Sabaci G, Bayer A, Mutlu FM, Karagul S, Yildirim E. Endophthalmitis after deadly weapon-related open-globe injuries: Risk factors, value of prophylactic antibiotics, and visual outcomes. Am J Ophthalmol 2002;133:62-69.
4. Lemley CA, Han DP. Endophthalmitis: A review of current evaluation and management. Retina 2007;27:662-680.
5. Tabbara KF, Hyndiuk RA. Infections of the Eye. Little, Brown: Boston, 1986.
6. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective randomised study. Br J Ophthalmol 1999;83:1050-1055.
7. Meredith TA, Aguilar HE, Drews C, Sawant A, Gardner S, Wilson LA, Grossniklaus HE. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc 1996;94:241-252; discussion 252-257.
8. Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo CD, Brown GC, Tasman W. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000;107:486-489.
9. Smith MA, Sorenson JA, D'Aversa G, Mandelbaum S, Udell I, Harrison W. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. J Infect Dis 1997;175:462-466.
10. Sanders-Bush E, Mayer SE, Hardman JG, Limbird LE. Goodman and Gilman's the Pharmacological Basis of Therapeutics: McGraw-Hill: New York; 2001, p. 273.
11. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 2005;24:587-611.
12. Falk NS, Beer PM, Peters GB III. Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis. Retina 2006;26:545-548.
13. Pathengay A, Shah GY, Das T, Sharma S. Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. Am J Ophthalmol 2006;141:938-940.
14. Peyman GA, Paque JT, Meisels HI, Bennett TO. Postoperative endophthalmitis: A comparison of methods for treatment and prophylaxis with gentamicin. Ophthalm Surg 1975;6:45-55.
15. Liu SM, Way T, Rodrigues M, Steidl SM. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch Ophthalmol 2000;118:803-806.
16. Flynn HW Jr, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Int Ophthalmol Clin 2004;44:115-137.
17. De Kaspar HM, Ta CN, Engelbert M, Mette M, Thiel M, Kampik A. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis. Retina 2008;28:326-332.
18. Gan IM, Ugahary LC, van Dissel JT, Feron E, Peperkamp E, Veckeneer M, Mulder PG, Platenkamp GJ, van Meurs JC. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis:Aprospective randomized trial. Graefes Arch Clin Exp Ophthalmol 2005;243:1200-1205.
19. Maxwell DP Jr, Brent BD, Diamond JG, Wu L. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis. Ophthalmology 1991;98:1370-1375.
20. Yildirim O, Oz O, Aslan G, Cinel L, Delialioglu N, Kanik A. The efficacy of intravitreal levofloxacin and intravitreal dexamethasone in experimental Staphylococcus epidermidis endophthalmitis. Ophthalm Res 2002;34:349-356.
21. Yoshizumi MO, Lee GC, Equi RA, Kim IT, Pitchekian-Halabi H, Adamu SA, Mondino BJ. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis. Retina 1998;18:130-135.
22. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1995;113:1324-1329.
23. Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol 1992;110:259-266.
24. Bucher RS, Hall E, Reed DM, Richards JE, Johnson MW, Zacks DN. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch Ophthalmol 2005;123:649-653.
25. Ataka S, Kurita K, Wada S, Tayeya K, Shiraki K. A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy. Int Ophthalmol 2007;27:51-54.
26. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
27. Yamashita T, Doi N, Sakamoto T. Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2004;242:679-681.
28. Jonas JB, Bleyl U. Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide. Br J Ophthalmol 2004;88:839-840.
29. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol 1999;117:1058-1062.
30. Jonas JB. Intravitreal triamcinolone acetonide: A change in a paradigm. Ophthalmic Res 2006;38:218-245.
31. Luke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Luke C, Bartz-Schmidt KU, Szurman P. The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina. Exp Eye Res 2008; 87:22-29.